Focus Meeting 5

MOLECULAR IMAGING AND THERANOSTICS
IN PROSTATE CANCER –
THE FUTURE BEGINS TODAY

February 2-4, 2023
Seville, Spain

 

Consensus Paper

We are delighted to announce that the consensus paper from the EANM Focus Meeting 5  entitled  ‘European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer’ has been published in the European Urology.

This publication results from the collaborative effort of all the panellists who contributed their expertise and knowledge to the discussion.

 

VIEW ARTICLE

 

Programme and Speakers

For a comprehensive overview of the EANM Focus Meeting 5, kindly click on the buttons below to access the scientific programme and the panellists´ profiles.

 

Scientific Programme    Panellists 

 

 

Sponsors

We express our sincere gratitude to the following companies for their sponsorship engagement:

 

Diamond Sponsor

Advanced Accelerator Applications

A Novartis Company

Platinum Sponsor

Monrol Spectrum Dynamics Medical Ltd.

Gold Sponsors

Blue Earth Diagnostics GE HealthCare ITM Isotope Technologies Munich SE Siemens Healthineers Telix Pharmaceuticals